162 related articles for article (PubMed ID: 37190029)
1. Molecular Spectroscopy Evidence of 1,3,5-Tris(4-carboxyphenyl)benzene Binding to DNA: Anticancer Potential along with the Comparative Binding Profile of Intercalation via Modeling Studies.
Wani TA; Zargar S
Cells; 2023 Apr; 12(8):. PubMed ID: 37190029
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Potential of Sulfonamide Moieties via In-Vitro and In-Silico Approaches: Comparative Investigations for Future Drug Development.
Wani TA; Zargar S; Alkahtani HM; Altwaijry N; Al-Rasheed LS
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175658
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
4. Investigating the anticancer properties of the two new platinum complexes with iso- and tert-pentylglycine by the DFT, molecular docking, and ADMET assessment and experimental confirmations.
Ramezani N; Eslami Moghadam M; Behzad M
J Biol Inorg Chem; 2021 May; 26(2-3):283-298. PubMed ID: 33616752
[TBL] [Abstract][Full Text] [Related]
5. Computational and Molecular Docking Studies of New Benzene Sulfonamide Drugs with Anticancer and Antioxidant Effects.
Mohamed HS; Abdelgawad MA; Hegab M; Hamza ZS; Nagdy AM; Ahmed SA; Ahmed OM; Ghoneim MM
Curr Org Synth; 2023; 20(3):339-350. PubMed ID: 36214306
[TBL] [Abstract][Full Text] [Related]
6. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
7. Docking studies on DNA intercalators.
Gilad Y; Senderowitz H
J Chem Inf Model; 2014 Jan; 54(1):96-107. PubMed ID: 24303988
[TBL] [Abstract][Full Text] [Related]
8. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
[TBL] [Abstract][Full Text] [Related]
9. Metal complexes as DNA intercalators.
Liu HK; Sadler PJ
Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anticancer potential of tetracene-5,12-dione (A01) and pyrimidine-2,4-dione (A02) via caspase 3 and lactate dehydrogenase cytotoxicity investigations.
Aziz M; Sarfraz M; Khurrum Ibrahim M; Ejaz SA; Zehra T; Ogaly HA; Arafat M; Al-Zahrani FAM; Li C
PLoS One; 2023; 18(12):e0292455. PubMed ID: 38127898
[TBL] [Abstract][Full Text] [Related]
11. Tris-chelated complexes of nickel(II) with bipyridine derivatives: DNA binding and cleavage, BSA binding, molecular docking, and cytotoxicity.
Anjomshoa M; Torkzadeh-Mahani M; Sahihi M; Rizzoli C; Ansari M; Janczak J; Sherafat Esfahani S; Ataei F; Dehkhodaei M; Amirheidari B
J Biomol Struct Dyn; 2019 Sep; 37(15):3887-3904. PubMed ID: 30309295
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer properties of a novel bis-intercalator.
Shen W; Deng H; Gao Z
Anticancer Agents Med Chem; 2013 May; 13(4):632-8. PubMed ID: 22931414
[TBL] [Abstract][Full Text] [Related]
13. The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work.
Martínez R; Chacón-García L
Curr Med Chem; 2005; 12(2):127-51. PubMed ID: 15638732
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
[TBL] [Abstract][Full Text] [Related]
15. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
El-Adl K; Ibrahim MK; Alesawy MSI; Eissa IH
Bioorg Med Chem; 2021 Jan; 30():115958. PubMed ID: 33360576
[TBL] [Abstract][Full Text] [Related]
16. Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators:
Farouk F; Elmaaty AA; Elkamhawy A; Tawfik HO; Alnajjar R; Abourehab MAS; Saleh MA; Eldehna WM; Al-Karmalawy AA
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2171029. PubMed ID: 36701269
[TBL] [Abstract][Full Text] [Related]
17. DNA-binding affinity, cytotoxicity, apoptosis, cell cycle inhibition and molecular docking studies of a new stilbene derivative.
Mehdipour M; Dehghan G; Yekta R; Hanifeh Ahagh M; Mahdavi M; Ghasemi Z; Fathi Z
Nucleosides Nucleotides Nucleic Acids; 2019; 38(2):101-118. PubMed ID: 30931800
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of Cu(II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: in vitro DNA binding, pBR322 cleavage, molecular docking studies and cytotoxicity against human cancer cell lines.
Tabassum S; Zaki M; Afzal M; Arjmand F
Eur J Med Chem; 2014 Mar; 74():509-23. PubMed ID: 24508781
[TBL] [Abstract][Full Text] [Related]
19. An integrated computational approach to identify GC minor groove binders using various molecular docking scoring functions, dynamics simulations and binding free energy calculations.
Soni MN; Kumar SP; S R KJ; Rawal RM; Pandya HA
J Biomol Struct Dyn; 2020 Aug; 38(13):3838-3855. PubMed ID: 31502527
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulation studies for DNA sequence recognition by reactive metabolites of anticancer compounds.
Tumbi KM; Nandekar PP; Shaikh N; Kesharwani SS; Sangamwar AT
J Mol Recognit; 2014 Mar; 27(3):138-50. PubMed ID: 24446378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
